Skip to Main Content

Author Details

Carrie Sougnez
The Broad Institute of Harvard and MIT
1998
64
58
PMIDPaper TitleJournal TitlePublished Year
30559381Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.Nature2019
30559381Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.Nature2019
27199251Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition.Nat Commun2016
27199251Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition.Nat Commun2016
26536169Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.N Engl J Med2016
26536169Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.N Engl J Med2016
25650244Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution.Genome Res2015
28843286Integrative Clinical Genomics of Advanced Prostate Cancer.Cell2015
25650244Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution.Genome Res2015
26061751Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.N Engl J Med2015
26181029Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell Carcinoma.JAMA Oncol2015
26000489Integrative clinical genomics of advanced prostate cancer.Cell2015
26638776Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution.Nat Commun2015
26466571Mutations driving CLL and their evolution in progression and relapse.Nature2015
26253028A Dominant Mutation in Human RAD51 Reveals Its Function in DNA Interstrand Crosslink Repair Independent of Homologous Recombination.Mol Cell2015
26119737Deficiency of UBE2T, the E2 Ubiquitin Ligase Necessary for FANCD2 and FANCI Ubiquitination, Causes FA-T Subtype of Fanconi Anemia.Cell Rep2015
26372948Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes.Nat Biotechnol2015
26410082Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets.Cancer Discov2015
28843286Integrative Clinical Genomics of Advanced Prostate Cancer.Cell2015
26466571Mutations driving CLL and their evolution in progression and relapse.Nature2015
26253028A Dominant Mutation in Human RAD51 Reveals Its Function in DNA Interstrand Crosslink Repair Independent of Homologous Recombination.Mol Cell2015
26410082Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets.Cancer Discov2015
26372948Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes.Nat Biotechnol2015
26638776Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution.Nat Commun2015
26181029Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell Carcinoma.JAMA Oncol2015
26119737Deficiency of UBE2T, the E2 Ubiquitin Ligase Necessary for FANCD2 and FANCI Ubiquitination, Causes FA-T Subtype of Fanconi Anemia.Cell Rep2015
26061751Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.N Engl J Med2015
26000489Integrative clinical genomics of advanced prostate cancer.Cell2015
24434212Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy.Cancer Cell2014
25490447Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia.Cancer Cell2014
25512523Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma.Proc Natl Acad Sci U S A2014
24434212Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy.Cancer Cell2014
24630729Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing.Cell2014
24894453Colon cancer-derived oncogenic EGFR G724S mutant identified by whole genome sequence analysis is dependent on asymmetric dimerization and sensitive to cetuximab.Mol Cancer2014
24752078Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer.Nat Biotechnol2014
24891321Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia.Blood2014
24823667Somatic retrotransposition in human cancer revealed by whole-genome and exome sequencing.Genome Res2014
24778153Somatic mutation as a mechanism of Wnt/β-catenin pathway activation in CLL.Blood2014
25490447Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia.Cancer Cell2014
25512523Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma.Proc Natl Acad Sci U S A2014
24752078Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer.Nat Biotechnol2014
24778153Somatic mutation as a mechanism of Wnt/β-catenin pathway activation in CLL.Blood2014
24823667Somatic retrotransposition in human cancer revealed by whole-genome and exome sequencing.Genome Res2014
24894453Colon cancer-derived oncogenic EGFR G724S mutant identified by whole genome sequence analysis is dependent on asymmetric dimerization and sensitive to cetuximab.Mol Cancer2014
24891321Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia.Blood2014
24630729Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing.Cell2014
23334666The genetic landscape of high-risk neuroblastoma.Nat Genet2013
24120142The somatic genomic landscape of glioblastoma.Cell2013
23770567Mutational heterogeneity in cancer and the search for new cancer-associated genes.Nature2013
24071852Pan-cancer patterns of somatic copy number alteration.Nat Genet2013
  • 1 - 50 of 128

Recommended Authors

The Hospital for Sick Children
Career Start Year 2012
Number of shared co-authors 14
University of Pennsylvania
Career Start Year 2010
Number of shared co-authors 5
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 21
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2010
Number of shared co-authors 31
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year 2008
Number of shared co-authors 39
National Human Genome Research Institute, US National Institutes of Health
Career Start Year 2008
Number of shared co-authors 6
Washington University School of Medicine
Career Start Year 2007
Number of shared co-authors 31
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2006
Number of shared co-authors 13
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 32
Manchester Cancer Research Centre, University of Manchester
Career Start Year 2006
Number of shared co-authors 23
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 20
Wellcome Sanger Institute
Career Start Year 2005
Number of shared co-authors 26
QIMR Berghofer Medical Research Institute
Career Start Year 2005
Number of shared co-authors 23
Wellcome Sanger Institute
Career Start Year 2004
Number of shared co-authors 29
University of Augsburg
Career Start Year 2004
Number of shared co-authors 21
University of California
Career Start Year 2003
Number of shared co-authors 9
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 25
Wellcome Sanger Institute
Career Start Year 2003
Number of shared co-authors 75
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 5
Washington University
Career Start Year 2003
Number of shared co-authors 58
Wellcome Sanger Institute
Career Start Year 2002
Number of shared co-authors 36
Wellcome Sanger Institute
Career Start Year 2002
Number of shared co-authors 31
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 32
St. Jude Children's Research Hospital
Career Start Year 1999
Number of shared co-authors 19
Universitat Pompeu Fabra
Career Start Year 1999
Number of shared co-authors 75
Wellcome Sanger Institute
Career Start Year 1996
Number of shared co-authors 57
QIMR Berghofer Medical Research Institute
Career Start Year 1996
Number of shared co-authors 35
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 9
Changhai Hospital, Second Military Medical University
Career Start Year 1992
Number of shared co-authors 51
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 77

Collaborators

Broad Institute of MIT and Harvard
Co-authored papers 46
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 43
Co-authored papers 35
Vanderbilt-Ingram Cancer Center, Vanderbilt University
Co-authored papers 34
Broad Institute
Co-authored papers 29
Co-authored papers 29
Co-authored papers 22
Broad Institute of Harvard and MIT
Co-authored papers 19
Cystic Fibrosis Foundation
Co-authored papers 16
Broad Institute of MIT and Harvard
Co-authored papers 16
The Broad Institute of Harvard and MIT
Co-authored papers 14
Broad Institute of Massachusetts Institute of Technology and Harvard
Co-authored papers 14
Co-authored papers 13
Co-authored papers 12
Co-authored papers 12
Co-authored papers 12
Broad Institute of MIT and Harvard
Co-authored papers 11
Co-authored papers 10
Co-authored papers 10
Co-authored papers 10
Co-authored papers 9
Co-authored papers 9
Co-authored papers 9
The Broad Institute of MIT and Harvard
Co-authored papers 8
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 8
Yale School of Medicine
Co-authored papers 7
Baylor College of Medicine
Co-authored papers 7
Co-authored papers 7
Co-authored papers 7
Co-authored papers 7